Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Certifies LGC Genomics as Sequencing Service Provider

Premium

This story was originally published Aug. 8.

Illumina has certified LGC Genomics to offer sequencing services on the Illumina platform. To become certified, LGC Genomics completed a two-phase process that included minimum data generation, data certification, and an on-site audit of its facility and processes.

Neils Kruize, sales director of LGC, said in a statement that the certification is "an important development for our next generation sequencing service."

Aside from sequencing, LGC offers genotyping services, assays, and reagents; DNA and RNA extraction services and products; instruments, reagents and consumables for molecular biology; pharmacogenetics and diagnostic services; and genomic services.

The company is headquartered in Teddington, UK, and its genomic sequencing service operations are based in Berlin, Germany.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.